These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9392847)

  • 1. Bioavailability and transport of peptides and peptide drugs into the brain.
    Egleton RD; Davis TP
    Peptides; 1997; 18(9):1431-9. PubMed ID: 9392847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of neuropeptide drugs that cross the blood-brain barrier.
    Egleton RD; Davis TP
    NeuroRx; 2005 Jan; 2(1):44-53. PubMed ID: 15717056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability.
    Witt KA; Gillespie TJ; Huber JD; Egleton RD; Davis TP
    Peptides; 2001 Dec; 22(12):2329-43. PubMed ID: 11786210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrovascular permeability to peptides: manipulations of transport systems at the blood-brain barrier.
    Zlokovic BV
    Pharm Res; 1995 Oct; 12(10):1395-406. PubMed ID: 8584471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide drug delivery into the central nervous system.
    Prokai L
    Prog Drug Res; 1998; 51():95-131. PubMed ID: 9949860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why study transport of peptides and proteins at the neurovascular interface.
    Pan W; Kastin AJ
    Brain Res Brain Res Rev; 2004 Aug; 46(1):32-43. PubMed ID: 15297153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Strategies for drug delivery to the brain across the blood-brain barrier].
    Tsuji A
    Nihon Rinsho; 1998 Mar; 56(3):613-8. PubMed ID: 9549345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of peptides and proteins through the blood-brain barrier.
    Bickel U; Yoshikawa T; Pardridge WM
    Adv Drug Deliv Rev; 2001 Mar; 46(1-3):247-79. PubMed ID: 11259843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport of opioid peptides into the central nervous system.
    Egleton RD; Abbruscato TJ; Thomas SA; Davis TP
    J Pharm Sci; 1998 Nov; 87(11):1433-9. PubMed ID: 9811502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polypeptide delivery across the blood-brain barrier.
    Pan W; Kastin AJ
    Curr Drug Targets CNS Neurol Disord; 2004 Apr; 3(2):131-6. PubMed ID: 15078188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivering peptides to the central nervous system: dilemmas and strategies.
    Banks WA; Kastin AJ; Barrera CM
    Pharm Res; 1991 Nov; 8(11):1345-50. PubMed ID: 1798668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The blood-brain barrier: principles for targeting peptides and drugs to the central nervous system.
    Begley DJ
    J Pharm Pharmacol; 1996 Feb; 48(2):136-46. PubMed ID: 8935161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-brain barrier and new approaches to brain drug delivery.
    Pardridge WM; Boado RJ; Black KL; Cancilla PA
    West J Med; 1992 Mar; 156(3):281-6. PubMed ID: 1595245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug targeting to the brain.
    de Boer AG; Gaillard PJ
    Annu Rev Pharmacol Toxicol; 2007; 47():323-55. PubMed ID: 16961459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of LDL receptor-targeting peptide vectors for
    Molino Y; David M; Varini K; Jabès F; Gaudin N; Fortoul A; Bakloul K; Masse M; Bernard A; Drobecq L; Lécorché P; Temsamani J; Jacquot G; Khrestchatisky M
    FASEB J; 2017 May; 31(5):1807-1827. PubMed ID: 28108572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permeability of the blood-brain barrier to peptides: an approach to the development of therapeutically useful analogs.
    Banks WA; Audus KL; Davis TP
    Peptides; 1992; 13(6):1289-94. PubMed ID: 1494505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routes for Drug Translocation Across the Blood-Brain Barrier: Exploiting Peptides as Delivery Vectors.
    Kristensen M; Brodin B
    J Pharm Sci; 2017 Sep; 106(9):2326-2334. PubMed ID: 28501469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNS drug design based on principles of blood-brain barrier transport.
    Pardridge WM
    J Neurochem; 1998 May; 70(5):1781-92. PubMed ID: 9572261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of an in vivo brain microdialysis technique to studies of drug transport across the blood-brain barrier.
    Deguchi Y; Morimoto K
    Curr Drug Metab; 2001 Dec; 2(4):411-23. PubMed ID: 11766991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogen bonding potential as a determinant of the in vitro and in situ blood-brain barrier permeability of peptides.
    Chikhale EG; Ng KY; Burton PS; Borchardt RT
    Pharm Res; 1994 Mar; 11(3):412-9. PubMed ID: 8008709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.